SOFTTEX CO., LTD
550A・--・--
SOFTTEX CO., LTD
550A・--・--
SOFTTEX CO., LTD. (Single Segment)
An independent IT company operating across two business axes: software development and medical IT
| Period | Current | Previous | Change |
|---|---|---|---|
| Revenue | ¥3,640 million | ¥3,565 million | ↑ |
| Operating Profit | ¥298 million | ¥286 million | ↑ |
| Ordinary Profit | ¥295 million | ¥289 million | ↑ |
| Equity Ratio | 69.3% | 63.1% | ↑ |
| Order Backlog (Total) | ¥847 million (Orders Received ¥3,820 million) | — | ↑ |
Business Details
The Company operates in a single segment related to system development, providing two services: Software Development Services (73.0% of revenue composition) and Medical IT Services (27.0% of revenue composition). As an independent company not affiliated with any specific capital group, it maintains a diverse client base spanning industries and sectors, serving public institutions to private companies through contract development, engineer staffing support, and ORCA implementation support. The Company operates exclusively within Japan and maintains a sound financial base with zero interest-bearing debt and an equity ratio of 69.3%.
Recent Overview
Medical IT led growth with a 5.9% year-on-year increase, while overall revenue increased 2.1% year-on-year
In FY2026 (ending March 2026), revenue was ¥3,639,630 thousand (up 2.1% year-on-year) and operating profit was ¥297,559 thousand (up 4.2% year-on-year). Software Development Services experienced delays in project progress with existing clients, delayed personnel reassignment following the termination of helpdesk operations, and a decline in disaster prevention projects; however, large-scale contract projects in Modernization Solutions remained steady. Medical IT Services expanded to ¥983,001 thousand (up 5.9% year-on-year) driven by rising demand for online insurance qualification confirmation implementation due to extended government subsidies and strengthened collaboration with partners. Orders received totaled ¥3,819,591 thousand (up 111.9% year-on-year), performing well, and the order backlog accumulated to ¥846,908 thousand (127.0% year-on-year).
Key Products
Growth Drivers
- Continued demand for online insurance qualification confirmation implementation in Medical IT Services due to extended government subsidies
- Steady trend in orders received and progress of large-scale contract projects in Modernization Solutions
- Increase in medical IT projects through expanded collaboration with electronic medical record manufacturers and medical device manufacturers
- Diverse client base and long-term continuous transactions leveraging its neutral position as an independent IT company
- Improved visibility of next-period revenue due to accumulation of order backlog (¥846,908 thousand, 127.0% year-on-year)
Risks
- Risk of increased recruitment and training costs and declining utilization rates due to worsening IT talent shortage
- Risk of revenue fluctuation due to dependence on a specific client (JBCC Corporation: 14.2% of revenue)
- Structural contraction of demand for traditional system development due to no-code development and AI advancement
- Decline in public-sector projects and intensifying competition in disaster prevention services
- Delayed improvement in profitability if the Company fails to move away from dependence on man-month based business
Last updated: June 23, 2026